Edge Capital achieves record assets under management with new ultra high net worth investor.
Latest investment by Regenosis Gero-Science Fund to file for FDA application for first-in-human trial to treat blindness.
Edge Capital has partnered with globally recognized scientists and physicians to start the REGENOSIS GERO-SCIENCE FUND.
Edge Capital leads sovereign investors, high net worth individuals and private companies to new investment opportunities in Asia.
Bringing a wealth of financial expertise and knowledge, we discover opportunities, assess the risks and act in your best interest.
Discover untapped markets and opportunities with us
“Our logo represents our seal of commitment towards a mutually beneficial arrangement.”